StonvexLoading…
StonvexStonvexStonvexCore line items from IBKR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $699.00M | $2.44B | $1.77B | $1.17B |
Operating Income | $1.29B | $4.77B | $3.47B | $2.16B |
Net Income | $1.17B | $4.36B | $3.16B | $1.97B |
EPS (Diluted) | $0.59 | $2.22 | $1.58 | $0.99 |
Total Assets | $218.75B | $203.24B | $200.22B | $181.47B |
Total Liabilities | $197.49B | $182.77B | $180.74B | $162.96B |
Cash & Equivalents | $5.08B | $4.96B | $5.13B | $4.69B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 448.37M | 443.86M | 442.51M | 440.46M |